Sanofi to invest 610 millions euros at two French vaccines sites

MARCY-L’ETOILE, France (Reuters) – French drugmaker Sanofi on Tuesday said it would invest 610 million euros ($679.4 million) at two of its French sites to turn them into a hub dedicated to research, development and production of vaccines.

Investments will help enhance the capacities of the group’s sites at Marcy-L’Etoile and Neuville-sur-Saone, central France.

The announcement came as Sanofi officials hosted a visit of French president Emmanuel Macron at Sanofi’s Marcy-L’Etoile facility on Tuesday.



Share this page Share on FacebookShare on TwitterShare on Linkedin

Discover the 'Made in France à Bahrain' Guide

'Made in France à Bahrain' - Edition 2021
is YOUR guide to the economic presence in Bahrain. Click here to view the online guide